Aggregometry and thromboelastography to identify the timing to trach a COVID-19 patient receiving both antiplatelet therapy and enoxaparin

Marco Tescione; Eugenio Vadalà; Graziella Marano; Andrea Bruni; Eugenio Garofalo; Ovidia Lavalle; Federico Longhini; Enzo Battaglia; Nicola Polimeni; Demetrio Labate; Sarah Caracciolo; Francesco Giordano; Massimo Caracciolo; Sebastiano Macheda

doi:10.1002/ccr3.3442

Aggregometry and thromboelastography to identify the timing to trach a COVID-19 patient receiving both antiplatelet therapy and enoxaparin

Clin Case Rep. 2021 Jan 9;9(3):1049-1054. doi: 10.1002/ccr3.3442. eCollection 2021 Mar.

Affiliations

¹ Anesthesia and Intensive Care Unit Grande Ospedale Metropolitano Reggio Calabria Italy.
² Anesthesia and Intensive Care Department of Medical and Surgical Sciences Magna Graecia University Catanzaro Italy.
³ Emergency and Acceptance Department Grande Ospedale Metropolitano Reggio Calabria Italy.

Abstract

In COVID-19 patients receiving enoxaparin and antiplatelets therapy, aggregometry and thromboelastography might be considered an adjunctive tool to identify the time to perform procedures at risk of bleeding, such as tracheostomy.

Keywords: COVID‐19; SARS‐CoV‐2; aggregometry; thromboelastography; tracheostomy.

Publication types

Case Reports